HCN3 contributes to the ventricular action potential waveform in the murine heart

Circulation Research

Volumn 109, Issue 9, 2011, Pages 1015-1023

  Fenske, Stefanie ^a   Mader, Robert ^a   Scharr, Andreas ^a   Paparizos, Christos ^a   Cao Ehlker, Xiaochun ^a   Michalakis, Stylianos ^a   Shaltiel, Lior ^a   Weidinger, Martha ^a   Stieber, Juliane ^b   Feil, Susanne ^c   Feil, Robert ^c   Hofmann, Franz ^d   Wahl Schott, Christian ^a   Biel, Martin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

cardiac electrophysiology; HCN3 knockout; hyperpolarization activated cyclic nucleotide gated channels; ventricular action potential; ventricular repolarization

Indexed keywords

CYCLIC NUCLEOTIDE GATED CHANNEL;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART FUNCTION; HEART RATE; HEART VENTRICLE FUNCTION; HYPERPOLARIZATION; MALE; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; MOUSE; MUSCLE CELL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REPOLARIZATION; T WAVE AMPLITUDE; TELEMETRY; WAVEFORM;

ACTION POTENTIALS; ANIMALS; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; ELECTROCARDIOGRAPHY; HEART RATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MYOCYTES, CARDIAC; SINOATRIAL NODE; VENTRICULAR FUNCTION;

EID: 80055010250     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.111.246173     Document Type: Article

References (48)

1. Brown HF, DiFrancesco D, Noble SJ. How does adrenaline accelerate the heart? Nature. 1979;280:235-236. (Pubitemid 9227914)
2. DiFrancesco D, Ducouret P, Robinson RB. Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science. 1989;243: 669-671. (Pubitemid 19064044)
3. Biel M, Wahl-Schott C, Michalakis S, Zong X. Hyperpolarization-activated cation channels: From genes to function. Physiol Rev. 2009;89: 847-885.
4. Santoro B, Tibbs GR. The HCN gene family: Molecular basis of the hyperpolarization-activated pacemaker channels. Ann N Y Acad Sci. 1999;868:741-764. (Pubitemid 29281192)
5. Kaupp UB, Seifert R. Molecular diversity of pacemaker ion channels. Annu Rev Physiol. 2001;63:235-257. (Pubitemid 32304318)
6. Herrmann S, Stieber J, Stockl G, Hofmann F, Ludwig A. HCN4 provides a 'depolarization reserve' and is not required for heart rate acceleration in mice. Embo J. 2007;26:4423-4432. (Pubitemid 350036626)
7. Ludwig A, Budde T, Stieber J, Moosmang S, Wahl C, Holthoff K, Langebartels A, Wotjak C, Munsch T, Zong X, Feil S, Feil R, Lancel M, Chien KR, Konnerth A, Pape HC, Biel M, Hofmann F. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. Embo J. 2003;22:216-224. (Pubitemid 36119427)
8. Stieber J, Herrmann S, Feil S, Loster J, Feil R, Biel M, Hofmann F, Ludwig A. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci USA. 2003;100:15235-15240. (Pubitemid 37518045)
9. Harzheim D, Pfeiffer KH, Fabritz L, Kremmer E, Buch T, Waisman A, Kirchhof P, Kaupp UB, Seifert R. Cardiac pacemaker function of HCN4 channels in mice is confined to embryonic development and requires cyclic AMP. Embo J. 2008;27:692-703. (Pubitemid 351273125)
10. Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med. 2006;354:151-157. (Pubitemid 43076712)
11. Nof E, Luria D, Brass D, Marek D, Lahat H, Reznik-Wolf H, Pras E, Dascal N, Eldar M, Glikson M. Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation. 2007;116:463-470. (Pubitemid 47450254)
12. Schulze-Bahr E, Neu A, Friederich P, Kaupp UB, Breithardt G, Pongs O, Isbrandt D. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest. 2003;111:1537-1545. (Pubitemid 38063286)
13. Ueda K, Nakamura K, Hayashi T, Inagaki N, Takahashi M, Arimura T, Morita H, Higashiuesato Y, Hirano Y, Yasunami M, Takishita S, Yamashina A, Ohe T, Sunamori M, Hiraoka M, Kimura A. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem. 2004;279:27194-27198. (Pubitemid 38812556)
14. Dobrzynski H, Nikolski VP, Sambelashvili AT, Greener ID, Yamamoto M, Boyett MR, Efimov IR. Site of origin and molecular substrate of atrioventricular junctional rhythm in the rabbit heart. Circ Res. 2003;93: 1102-1110. (Pubitemid 37485042)
15. Hoesl E, Stieber J, Herrmann S, Feil S, Tybl E, Hofmann F, Feil R, Ludwig A. Tamoxifen-inducible gene deletion in the cardiac conduction system. J Mol Cell Cardiol. 2008;45:62-69.
16. Cerbai E, Mugelli A. I(f) in non-pacemaker cells: Role and pharmacological implications. Pharmacol Res. 2006;53:416-423. (Pubitemid 43729046)
17. Hiramatsu M, Furukawa T, Sawanobori T, Hiraoka M. Ion channel remodeling in cardiac hypertrophy is prevented by blood pressure reduction without affecting heart weight increase in rats with abdominal aortic banding. J Cardiovasc Pharmacol. 2002;39:866-874. (Pubitemid 34538817)
18. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ. Hyperpolarizationactivated inward current in ventricular myocytes from normal and failing human hearts. Circulation. 1998;97:55-65. (Pubitemid 28036155)
19. Herrmann S, Stieber J, Ludwig A. Pathophysiology of HCN channels. Pflugers Arch. 2007;454:517-522. (Pubitemid 46872890)
20. Stillitano F, Lonardo G, Zicha S, Varro A, Cerbai E, Mugelli A, Nattel S. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol. 2008;45:289-299.
21. Stieber J, Stockl G, Herrmann S, Hassfurth B, Hofmann F. Functional expression of the human HCN3 channel. J Biol Chem. 2005;280: 34635-34643. (Pubitemid 41504594)
22. Mistrik P, Mader R, Michalakis S, Weidinger M, Pfeifer A, Biel M. The murine HCN3 gene encodes a hyperpolarization-activated cation channel with slow kinetics and unique response to cyclic nucleotides. J Biol Chem. 2005;280:27056-27061. (Pubitemid 41040742)
23. Chaplan SR, Guo HQ, Lee DH, Luo L, Liu C, Kuei C, Velumian AA, Butler MP, Brown SM, Dubin AE. Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain. J Neurosci. 2003;23: 1169-1178. (Pubitemid 36258896)
24. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998;98:1928-1936. (Pubitemid 28509291)
25. Patel C, Burke JF, Patel H, Gupta P, Kowey PR, Antzelevitch C, Yan GX. Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: A century of controversy. Circ Arrhythm Electrophysiol. 2009;2:80-88.
26. Azene EM, Xue T, Li RA. Molecular basis of the effect of potassium on heterologously expressed pacemaker (HCN) channels. J Physiol. 2003; 547:349-356. (Pubitemid 36304969)
27. Zaniboni M, Cacciani F, Groppi M. Effect of input resistance voltagedependency on DC estimate of membrane capacitance in cardiac myocytes. Biophys J. 2005;89:2170-2181. (Pubitemid 41233570)
28. Cranefield PF, Hoffman BF. Propagated repolarization in heart muscle. J Gen Physiol. 1958;41:633-649.
29. Weidmann S. Resting and action potentials of cardiac muscle. Ann N Y Acad Sci. 1957;65:663-678.
30. Weidmann S. Membrane excitation in cardiac muscle. Circulation. 1961; 24:499-505.
31. Sampson KJ, Henriquez CS. Electrotonic influences on action potential duration dispersion in small hearts: A simulation study. Am J Physiol Heart Circ Physiol. 2005;289:H350-H360. (Pubitemid 40934121)
32. Zaniboni M, Pollard AE, Yang L, Spitzer KW. Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. Am J Physiol Heart Circ Physiol. 2000;278:H677-H687. (Pubitemid 30152522)
33. Xu H, Li H, Nerbonne JM. Elimination of the transient outward current and action potential prolongation in mouse atrial myocytes expressing a dominant negative kv4 alpha subunit. J Physiol. 1999;519(Pt 1):11-21. (Pubitemid 29417799)
34. Bondarenko VE, Szigeti GP, Bett GC, Kim SJ, Rasmusson RL. Computer model of action potential of mouse ventricular myocytes. Am J Physiol Heart Circ Physiol. 2004;287:H1378-H1403. (Pubitemid 39096689)
35. Wang LJ, Sobie EA. Mathematical model of the neonatal mouse ventricular action potential. Am J Physiol Heart Circ Physiol. 2008;294: H2565-H2575.
36. Kass RS. Genetically induced reduction in small currents has major impact. Circulation. 1997;96:1720-1721. (Pubitemid 27400723)
37. van Welie I, Wadman WJ, van Hooft JA. Low affinity block of native and cloned hyperpolarization-activated Ih channels by Ba2f ions. Eur J Pharmacol. 2005;507:15-20. (Pubitemid 40126835)
38. Drici MD, Arrighi I, Chouabe C, Mann JR, Lazdunski M, Romey G, Barhanin J. Involvement of IsK-associated Kchannel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. Circ Res. 1998;83:95-102. (Pubitemid 28322103)
39. Noble D. Experimental and theoretical work on excitation and excitationcontraction coupling in the heart. Experientia. 1987;43:1146-1150. (Pubitemid 17167242)
40. Goldman Y, Morad M. Ionic membrane conductance during the time course of the cardiac action potential. J Physiol. 1977;268:655-695. (Pubitemid 8154319)
41. Spitzer KW, Steinhaus BM, Hirai M, Haws CW, Burgess MJ. Modulation of collision-induced changes in canine heart repolarization by cycle length. J Electrocardiol. 1991;24:43-52.
42. Zaniboni M, Riva I, Cacciani F, Groppi M. How different two almost identical action potentials can be: A model study on cardiac repolarization. Math Biosci. 228:56-70.
43. Thorneloe KS, Liu XF, Walsh MP, Shimoni Y. Transmural differences in rat ventricular protein kinase C epsilon correlate with its functional regulation of a transient cardiac Kcurrent. J Physiol. 2001;533: 145-154. (Pubitemid 32499367)
44. Costantini DL, Arruda EP, Agarwal P, Kim KH, Zhu Y, Zhu W, Lebel M, Cheng CW, Park CY, Pierce SA, Guerchicoff A, Pollevick GD, Chan TY, Kabir MG, Cheng SH, Husain M, Antzelevitch C, Srivastava D, Gross GJ, Hui CC, Backx PH, Bruneau BG. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell. 2005;123:347-358. (Pubitemid 41457222)
45. Nabauer M, Beuckelmann DJ, Uberfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation. 1996;93:168-177. (Pubitemid 26006581)
46. Li GR, Feng J, Yue L, Carrier M. Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle. Am J Physiol. 1998;275:H369-H377.
47. Cerbai E, De Paoli P, Sartiani L, Lonardo G, Mugelli A. Treatment with irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive rats. J Cardiovasc Pharmacol. 2003;41:804-812. (Pubitemid 36523185)
48. Cerbai E, Crucitti A, Sartiani L, De Paoli P, Pino R, Rodriguez ML, Gensini G, Mugelli A. Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes. Cardiovasc Res. 2000;45:388-396. (Pubitemid 30069504)